Enzymatic Determination of Unbound D-Mannose in Serum by Pitkänen, Elja et al.
Eur J Clin Chem Clin Biochem 1997; 35(10):761 -766 © 1997 by Walter de Gruyter · Berlin · New York
Enzymatic Determination of Unbound D-Mannose in Serum
Elja Pitk nen1, Olli Pitk nen2 and Lasse Uotila1
1 Kliinisen kemian laitos, Helsingin yliopistollinen keskussairaala, Helsinki, Finland
2 Lasten ja Nuorten sairaala, Helsingin yliopistollinen keskussairaala, Helsinki, Finland
Summary: Mannose is an aldohexose component of a number of glycoproteins in cellular membranes and blood
plasma. Free (unbound) mannose is a normal blood plasma constituent and its concentration is elevated in diabetes
mellitus and chronic glomerulonephritis. We devised an enzymatic method for the determination of free mannose
in which mannose is converted to glucose-6-phosphate and measured spectrophotometrically using glucose-6-phos-
phate dehydrogenase and nicotinamide adenine dinucleotide phosphate (NADP). Accumulation of reduced NADP
in the assay was verified by spectral analysis and by finding rapid disappearance of absorbance at 340 nm on
addition of glutathione reductase and oxidized glutathione into the reaction mixture.
The method necessitates prior removal of glucose from the samples. This we accomplished using glucose-6-phos-
phate dehydrogenase and a surplus amount of NADP, followed by elimination of reduced NADP by acidification
of the reaction mixture. The assays may be run in parallel for expediency.
Concentration of free mannose in serum was 18.5 ±5.5 μηιοΙ/1 in healthy fasting female adults. The analytical
recovery was 90.2 ± 10.2% and the between-run imprecision was 13.5% (18.5 ± 5.5 μηιοΙ/1, mean ± SD) and
10.4% (75.3 ± 10.3 μπιοΐ/l). The assay showed rectilinearity up to 220 μηιοΐ/l, which covers the measuring range
to which the mannose concentrations in normal and clinical samples may be expected to fall.
Introduction
Mannose is an important carbohydrate component of
glycoproteins that are attached to the cellular mem-
branes. Furthermore, mannose is an oligosaccharide con-
stituent of fibrinogen, apolipoproteins, immunoglobulins
and numerous other glycoproteins that circulate in blood
plasma. Changes in the content of protein-bound
hexoses in diseases have been reported (1—4).
Mannose is incorporated in endoplasmic reticulum into
the oligosaccharide assembly of glycoproteins using a
pathway with phosphorylated dolichol as the sugar ac-
ceptor and transfer vehicle. Mannose is synthesized from
glucose via a cellular enzymatic pathway through phos-
phorylated hexose intermediates. It is possible that the
trimming of oligosaccharides of newly synthesized gly-
coproteins in the Golgi apparatus and the lysosomal
breakdown of glycoproteins form other sources of intra-
cellular mannose.
The concentration of free (unbound) mannose in human
plasma has been measured with enzymatic methods (5,
6) and by means of gas-liquid chromatography (3,
7—10) or gas-liquid chromatography/mass spectrometry
(11). The enzymatic methods build on the use of a chain
of enzyme reactions to convert mannose to glucose
phosphate and the subsequent measurement of the glu-
cose-6-phosphate formed. The technique necessitates
prior elimination of glucose from the samples of serum,
as glucose concentration greatly overruns the concentra-
tion of mannose. Elimination of glucose has been ac-
complished using glucose oxidase and catalase. How-
ever, the use of glucose oxidase is charged with the pro-
vision that the enzyme has slight oxidizing activity on
mannose (12) and during removal of glucose some loss
of mannose may occur.
In the present study the content of glucose and fructose
in the samples was reduced using hexokinase1), glucose-
6-phosphate dehydrogenase1), and glucose-6-phosphate
isomerase1) in the presence of adenosine triphosphate
(ATP) and nicotinamide adenine dinucleotide phosphate
(NADP). Glucose and fructose were converted to glu-
cose-6-phosphate in the reaction and then oxidized to 6-
phosphogluconate. Reduced NADP that accumulated in
the reaction was destroyed by acidification of the reac-
tion mixture (13). Mannose was then converted to glu-
cose-6-phosphate by mannose-6-phosphate isomerase
and glucose-6-phosphate isomerase, and the amount of
glucose-6-phosphate formed was estimated by spectro-
photometric measurement of the increase in absorbance
at 340 nm in the presence of glucose-6-phosphate dehy-
') Enzymes:
Hexokinase (EC 2.7.1.1)
Glucose-6-phosphate dehydrogenase (EC 1.1.1.49)
Glucose-6-phosphate isomerase (EC 5.3.1.9)
Glutathione reductase (EC 1.6.4.2)
Mannose-6-phosphate isomerase (EC 5.3.1.8)
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drogenase and NADP (5, 6, 14). The sequence of reac-
tions is outlined in figure 1.
Methods
Reagents
D-glucose/D-fructose UV-test kit and mannose-6-phosphate iso-
merase enzyme suspension were purchased from Boehringer
(Mannheim, Germany). D-mannose, oxidized glutathione, yeast
glutathione reductase (Grade III, 2500 units/0.7 ml) and NADP
were purchased from Sigma Chemical (St. Louis, MO, USA). ATP
was obtained from Merck (Darmstadt, Germany). Sephadex G-25
PD-10 columns were purchased from Pharmacia, Uppsala, Sweden.
Procedure
The solutions of Z)-glucose/Z)-fructose UV-test kit were modified
for the determination of mannose.
Measurement of mannose in serum samples (tab. 1)
Hyperglycaemic samples were diluted with water to a glucose con-
centration of 5—6 mmol/1. Serum (200 μΐ) or diluted serum (200
μΐ) was mixed with 800 μΐ of solution 1, followed by 10 μΐ (2.85 U
hexokinase and 1.42 U glucose-6-phosphate dehydrogenase) of so-
lution 2 and 7 μΐ (4.9 U glucose-6-phosphate isomerase) of solution
3. The mixture was incubated for four minutes at 37 °C to remove
glucose and fructose from the sample. Reduced NADP was then
destroyed by adding 0.1 mol/1 hydrochloric acid (200 μΐ) to the
reaction mixture, followed one minute later by addition of 0.1 mol/1
sodium hydroxide (120 μΐ).
The make-up was then reconstituted by adding 7 μΐ of solution 2
and 5 μΐ of solution 3, and incubated for four minutes at 37 °C to
eliminate any remaining glucose and fructose. An aliquot (650 μΐ)
of the sample was then taken in a separate tube and spiked with
2 μΐ (0.6 U) mannose-6-phosphate isomerase suspension. Ammo-
nium sulphate (3.2 mol/1, 2 μΐ) was added to the remaining aliquot
(650 μΐ), and was used as the blank reaction. The A340 difference
Preparation of working solutions
The buffer solution (designated solution 1 in the test kit): To 6 ml
of the buffer solution 10 ml water was added and the solution was
fortified with addition of 42 mg NADP · Na and 20 mg ATP · 2Na.
Enzyme suspensions (solutions 2 and 3): hexokinase, glucose-6-
phosphate dehydrogenase and glucose-6-phosphate isomerase en-
zymes are supplied in the test kit as suspensions in 3.2 mol/1 am-
monium sulphate solution. Ammonium ion is known to markedly
inhibit the mannose-6-phosphate isomerase reaction (15) and in our
preliminary experiments we noted that application of these un-
treated enzyme preparations resulted in a marked slowdown of
mannose-6-phosphate isomerase reaction. This inhibition necessi-
tated removal of ammonium sulphate from the enzyme prepara-
tions. Solution 2 (containing 285 kU/1 hexokinase and 142 kU/1
glucose-6-phosphate dehydrogenase) and solution 3 (containing
700 kU/1 glucose-6-phosphate isomerase) suspensions were centri-
fuged in a Coleman Minifuge for eight minutes. The supernatants
were removed and the enzyme-rich pellets were resuspended to the
original volume with a 1 + 1 (by vol) mixture of physiological
saline and bovine serum albumin (10 g/1).
Mannose-6-phosphate isomerase enzyme suspension (300 kU/1)
was used untreated.
Oxidized glutathione (GSSG) was dissolved in distilled water to
make 13.5 mmol/1, and glutathione reductase was used as the com-
mercial preparation.
Mannose was stored as a 40 mmol/1 stock solution in water.
Tab. 1 Work-chart of mannose determination.
Solution 1 (NADP/ATP) 800 μΐ
Sample 200 μΐ
Solution 2 10 μΐ
(hexokinase/glucose-6-phosphate dehydrogenase)
Solution 3 (glucose-6-phosphate isomerase) 7 μΐ
Shaking, 4 min incubation at 37 °C
0.1 mol/1 HC1 200 μΐ
Shaking, l min incubation
0.1 mol/1 NaOH 120μ1
Shaking
Solution 2 7 μΐ
(hexokinase/glucose-6-phosphate dehydrogenase)
Solution 3 (glucose-6-phosphate isomerase) 5 μΐ
Shaking, 4 min incubation at 37 °C
Shaking, division of the composition in two 650 μΐ portions
Blank Sample
Composition 650 μΐ 650 μΐ
Ammonium sulphate, 3.2 mol/1 2 μΐ
Mannose-6-phosphate isomerase suspension 2 μΐ
Shaking, 10 min incubation at 37 °C




Fig. 1 Enzymatic steps in the removal of glucose and fructose
from serum (1) and in the subsequent determination of mannose
(2), NADP = nicotinamide adenine dinucleotide phosphate, P
phosphate.
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between sample and blank was read after incubation of 10 minutes
at 37 °C in an automatic spectrophotometer (Kone C clinical ana-
lyzer, Kone, Espoo, Finland).
Calculation: The concentration of mannose in serum (μηιοΐ/l) de-
rives from the formula
1100 Χ ΔΑ340 (sample - blank) X dilution factor.
Experiments with glutathione reductase
The experiments were carried out in the reaction mixtures as soon
as the absorbance readings for mannose determination were com-
pleted. To 650 μΐ of reaction mixture, oxidized glutathione (GSSG,
20 μΐ) and glutathione reductase (0.2 μΐ) were added, and the
change in A340 was recorded for five minutes.
Measurement of mannose-6-phosphate isomerase
activity in serum
To test the presence of mannose-6-phosphate isomerase in samples
of serum we removed glucose from samples by allowing 1 ml ali-
quots of serum to pass through Sephadex G-25 PD-10 columns,
equilibrated with 25 mmol/1 triethanolamine buffer, pH 7.4. The
column was then rinsed with 1.5 ml buffer solution and the protein
fraction collected in 2.7 ml buffer. It was checked that mannose-
6-phosphate isomerase, added to serum, was recovered in this frac-
tion.
The solutions of the D-glucose/D-fructose UV-test kit without
modification were used in the measurement of mannose-6-phos-
phate isomerase activity in the protein fraction.
To solution 1 (300 μΐ) was added water (300 μΐ), solution 2 (hexo-
kinase/glucose-6-phosphate dehydrogenase, 5 μΐ), solution 3 (glu-
cose-6-phosphate isomerase, 5 μΐ) and mannose (25 μΐ). The mix-
ture was incubated for five minutes at 37 °C to eliminate glucose,
which occurs as a minor impurity in the commercial mannose prep-
aration. Then an aliquot (500 μΐ) of the protein fraction was added
and the change in A340 was monitored for 10 minutes. The linear
part of the curve was taken to represent mannose-6-phosphate iso-
merase activity. Another similar reaction mixture omitting the addi-
tion of protein fraction served as the blank reaction.
Statistics
Each single datum of serum mannose concentration represents the
average of duplicate samples. The data are presented as mean
± SD, N = number of experiments. The linear correlations were
calculated using linear regression analysis. For calculation of the
statistical difference Student's impaired t-test was used and
ρ < 0.05 was considered significant.
Results
Time course of the mannose-6-phosphate
isomerase reaction
Addition of mannose-6-phosphate isomerase resulted in
a rapid increase in A340 over the first 3 minutes of incu-
bation, followed by a slower increase over the next
seven minutes. Beyond the 10 minute time point A340
changed insignificantly (fig. 2). The spectrum character-
istics taken at the end of incubation were compatible
with the spectrum produced by reduced NADP (fig. 3).
An experiment with three further sera produced similar
spectrum characteristics and time course profiles.
Experiments with glutathione reductase
The experiments were conducted to obtain further proof
that the increase in A340 that was produced by addition
of mannose-6-phosphate isomerase in the reaction mix-
tures was due to reduction of NADP. The rationale of
the test stems from the knowledge that glutathione re-
ductase has the capacity to avidly reduce oxidized gluta-
thione in a reaction that consumes reduced NADP and
that the balance strongly favours formation of reduced
glutathione (16). We postulated accordingly that any re-
duced NADP present in our samples should be rapidly
oxidized by glutathione reductase in the presence of oxi-
dized glutathione. In these experiments it was noted that
addition of oxidized glutathione and glutathione reduc-
tase to mannose-6-phosphate isomerase-treated and
blank sample reduced A340 and that the reaction was
rapid (fig. 2). Within two minutes, A340 of blank, sam-
ple, and sample supplemented with mannose approached
each other and no decrease in absorbance was seen in
further readings. The glutathione reductase test was car-
ried out in five further samples with similar outcome:
A340 declined within two minutes, the absorbances of
sample and blank decreased to a similar baseline value













Fig. 2 Time course of absorbance in the determination of man-
nose in serum (middle curve), serum fortified with 150 umol/1
mannose (upper curve), and blank reaction (addition of mannose-
6-phosphate isomerase omitted, lower curve). The additions of
mannose-6-phosphate isomerase, oxidized glutathione (GSSG),
and glutathione reductase are indicated by arrows.
300 320 340 360 380 400 420 440 460
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Fig. 3 Spectrum characteristics at the end of incubation of a sam-
ple of serum (middle curve), serum fortified with 150 μηιοΐ/ΐ man-
nose (upper curve), and blank reaction (addition of mannose-6-
phosphate isomerase omitted, lower curve).
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Method validation
Precision
The estimation of the between-series variation was ob-
tained from routine unknowns that were measured in
duplicate in different runs. The variation coefficient
(CV) was 13.5% (mannose concentration 18.4 ±5.5
μιηοΐ/ΐ, Ν = 8) and 10.4% in samples with a higher
mannose concentration (75.3 ± 10.3 μπιοΙ/1, Ν = 12).
The within-series variation was estimated by running
measurements in duplicate. CV was 6.8% (mannose
concentration 50.7 ± 43.2 μηιοΐ/l, Ν = 14).
Analytical recovery
Recovery obtained from samples of serum supple-
mented with mannose (200 μιηοΐ/ΐ) was 90.2 ± 10.2%
(N = 28).
Linearity
The linear range was tested by varying the amount of
mannose added to a serum sample containing a natural
concentration of 25 μηιοΐ/l mannose. The recovery
showed linearity in the range of 20—220 μιηοΐ/ΐ man-
nose, as depicted in figure 4. The regression analysis
gave r = 0.998. The regression characteristics for ob-
served/expected were: slope = 0.905, intercept = 20.7
μηιοΐ/ΐ.
Mannose concentration in serum
Serum mannose concentration was estimated in blood
samples collected during forenoon from healthy female
laboratory technicians that had fasted overnight. The
concentration was 18.5 ± 5.5 μπιοΐ/l (Ν = 6). The blood
glucose concentration at the time of collection was 4.4
±1.0 mmol/1. The mannose concentration was 75.3
±6.1 μηιοΙ/1 (Ν = 12) in serum of diabetic patients with
blood glucose concentration ranging 6.2—16.0 mmol/1.
A close positive correlation between serum glucose and





Fig. 4 Linearity of mannose determination in serum, depicted as
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Fig. 5 Correlation between glucose and mannose concentration




The measurement of mannose-6-phosphate isomerase
activity in serum was deemed necessary since mannose-
6-phosphate isomerase, if present in serum, may lead to
a loss of mannose during the processing of the sample
for removal of glucose (tab. 1). Mannose-6-phosphate
isomerase activity was measured in 30 samples of se-
rum, including six samples taken from apparently heal-
thy individuals and six patients with diabetes mellitus
with blood sugar concentrations 6—12.5 mmol/1. The
change in A340 during the photometric measurement was
very low, hardly distinguishable from the baseline level.
The highest activity encountered was 3 U/l. The experi-
ments indicated that the mannose-6-phosphate iso-
merase activity in the samples of serum, if any, was too
low for its accurate measurement.
Rationale of another set of experiments was the hypo-
thesis of encountering a sample of serum with consider-
able mannose-6-phosphate isomerase activity. In these
experiments we determined the concentration of man-
nose in samples supplemented with mannose-6-phos-
phate isomerase (100 and 200 U/l) and mannose (200
μιηοΐ/ΐ). The presence of 100 U/l mannose-6-phosphate
isomerase in the sample led to a loss of 10 μηιοΙ/1 man-
nose (4.0% of the amount of mannose in the sample).
Presence of 200 U/l mannose-6-phosphate isomerase led
to a loss of 17.8 μηιοΙ/1 mannose (7.1% of the amount
of mannose in the sample). It was inferred that the loss
of mannose in samples with mannose-6-phosphate iso-
merase activity up to 200 U/l in serum would be
gradeable but remain moderate.
Discussion
Removal of glucose using hexokinase and glucose-6-
phosphate dehydrogenase and disintegration by acidifi-
cation of NADPH produced, emerged as a functionable
and efficient procedure in the preparation of samples
for the determination of mannose. The experience that
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glucose-6-phosphate dehydrogenase, while highly active
with glucose-6-phosphate, is inactive with mannose-6-
phosphate (17) makes it likely that no loss of mannose
was taking place during the procedure. In this rating the
present procedure may be superior to earlier procedures
relying on glucose oxidase, an enzyme with broader sub-
strate specificity. The power of hexokinase to phosphoryl-
ate both anomeric forms of mannose (18) is an advantage
as it ensures that the phosphorylation of mannose quickly
runs to completion. The strict substrate specificity of man-
nose-6-phosphate isomerase to convert mannose-6-phos-
phate to fructose-6-phosphate (14) imparts high specific-
ity to the determination of mannose.
Addition of mannose-6-phosphate isomerase, initiating
the final step in the procedure, produced an increase in
A34o that appeared to follow first order kinetics. The
time course was similar in natural samples and in sam-
ples supplemented with mannose. The spectrum data
and the outcome of the glutathione/glutathione reductase
test provided unequivocal evidence that the increase in
absorbance was due to accumulation of reduced NADP.
A gradual, albeit moderate, increase in A340 was also
noted in the blank reaction (mannose-6-phosphate iso-
merase omitted). The cause of the increase in the blank
reaction remained unknown, but we found that leftover
glucose and fructose stemming from an incomplete glu-
cose removal step may occasionally form a source for
the elevation.
The perspective of confronting samples with high man-
nose-6-phosphate isomerase activity is a crucial issue,
facing enzymatic methods of mannose determination of
the present category. It was reassuring to note that our
study with 30 test sera produced no evidence for the
presence of mannose-6-phosphate isomerase in serum.
Furthermore, our search in the Medline library did not
track down any report on occurrence of mannose-6-
phosphate isomerase in serum. The data obtained seem
to imply that occurrence in serum of the enzyme may
remain a hypothetical consideration. Brain, muscle, kid-
ney, liver and erythrocytes are tissues rich in mannose-
6-phosphate isomerase (19) and our study did not incor-
porate samples collected under acute conditions of
these tissues.
The mannose concentrations found in normal individ-
uals are not unlike the values found in an earlier study
using an enzymatic method (6), but somewhat lower
than the concentrations found with mass spectrometry
(11, 20, 21). The test subjects singled out for the present
study were lean fasting females under 45 years of age
and it is possible that disparities in the test subject selec-
tion and sample collection may account for at least a
part of the departure. High mannose concentrations
found in hyperglycaemic patients tally with earlier data
from several laboratories dealing with the concentration
of mannose in diabetes mellitus (3, 5, 7, 8, 20). The
correlation found between mannose and glucose is in
compliance with earlier reports of a positive relationship
between the concentrations of mannose and glucose in
serum (5, 20).
An enzymatic assay of Z)-mannose in serum using glu-
cose-6-phosphate dehydrogenase, glucose-6-phosphate
isomerase and mannose-6-phosphate isomerase was is-
sued quite recently (22). In the assay, the content of glu-
cose was minimized by using glucose-specific glucoki-
nase and glucose-6-phosphate dehydrogenase. Treat-
ment with weak ion exhanger depleted the samples from
anionic reaction products, including reduced NADP. In
keeping with the report, our study supports the view that
the use of glucose-6-phosphate dehydrogenase and man-
nose-6-phosphate isomerase provides a sound footing
for a specific and high sample throughput measurement
of mannose.
Our knowledge of mannose metabolism in human dis-
ease is limited. However, the few studies so far con-
ducted have produced intriguing observations on serum
mannose concentrations in diabetes mellitus, Candida
infection, renal disease, and hyperlipaemia associated
with chronic nephritis (3, 5, 8, 20, 21). Development
of simple enzymatic tests may promote investigation of
mannose and other members of the interesting family of
non-glucose polyols (monosaccharides) that circulate in
serum and body fluids.
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